Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone for prevention of PTSD after acute trauma
MOH_2022-02-22_010633Phase 3Recruiting
- Sponsor
- פרופ' יוסף זהר
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing hydrocortisone with Placebo comparator (2 arms). Started Feb 2020; status: recruiting.
02
Drugs
hydrocortisone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on MOH_2022-02-22_010633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2022-02-22_010633.